Wiley

CNS Drug Reviews Template

Write in a clean editor, then format for CNS Drug Reviews in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the CNS Drug Reviews format

CNS Drug Reviews is a peer-reviewed journal published by Wiley, covering Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Cholinesterase and Neurodegenerative Diseases.

PublisherWiley
Reference styleAuthor–year (Chicago)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." CNS Drug Reviews 12 (3): 45–58.

Formats any DOI in CNS Drug Reviews style. No sign-up.

Publishes research inNeuroscience and Neuropharmacology Research Receptor Mechanisms and Signaling Cholinesterase and Neurodegenerative Diseases Neurotransmitter Receptor Influence on Behavior Nicotinic Acetylcholine Receptors Study
ISSN1080-563X
h-index69
i10-index202
Total citations16,861
Top institutions publishing hereYale University
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in CNS Drug Reviews per year

27
1997
34
1998
57
1999
59
2000
29
2001
32
2002
28
2003
36
2004
21
2005
33
2006
36
2007
1
2010

Citation impact of CNS Drug Reviews by publication year

217
1997
544
1998
442
1999
316
2000
2.8K
2001
1.6K
2002
1.8K
2003
1.4K
2004
1.1K
2005
3.6K
2006
2.3K
2007
0
2010

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in CNS Drug Reviews

A Review of the Pharmacological and Clinical Profile of Mirtazapine

Sami Anttila, Esa Leìnonen · 1 Sep 2001

The novel antidepressant mirtazapine has a dual mode of action. It is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT2 and 5-HT3 receptors. It enhances, therefore, the release of norepinephrine and 5-HT1A-mediated serotonergic transmission. This dual mode of action may conceivably…

Paracetamol: New Vistas of an Old Drug

Alfio Bertolini, Anna Ferrari, Alessandra Ottani et al. · 1 Sep 2006

Paracetamol (acetaminophen) is one of the most popular and widely used drugs for the treatment of pain and fever. It occupies a unique position among analgesic drugs. Unlike NSAIDs it is almost unanimously considered to have no antiinflammatory activity and does not produce gastrointestinal damage or untoward cardiorenal effects. Unlike opiates it is almost ineffective…

Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597)

Daniele Piomelli, Giorgio Tarzia, Andrea Duranti et al. · 1 Mar 2006

In the present article, we review the pharmacological properties of KDS-4103 (URB597), a highly potent and selective inhibitor of the enzyme fatty-acid amide hydrolase (FAAH), which catalyzes the intracellular hydrolysis of the endocannabinoid anandamide. In vitro, KDS-4103 inhibits FAAH activity with median inhibitory concentrations (IC(50)) of 5 nM in rat brain membranes and 3 nM…

The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease

Michael A. Rogawski, Gary L. Wenk · 1 Sep 2003

Memantine has been demonstrated to be safe and effective in the symptomatic treatment of Alzheimer's disease (AD). While the neurobiological basis for the therapeutic activity of memantine is not fully understood, the drug is not a cholinesterase inhibitor and, therefore, acts differently from current AD therapies. Memantine can interact with a variety of ligand-gated ion…

Paroxetine: A Review

Michel Bourin, Pierre Chue, Yannick Guillon · 1 Mar 2001

Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI) with currently approved indications for the treatment of depression, obsessive-compulsive disorder, panic disorder and social phobia. It is also used in the treatment of generalized anxiety disorder, post traumatic stress disorder, premenstrual dysphoric disorder and chronic headache. Paroxetine, a phenylpiperidine derivative, is the most potent…

CNS Drug Reviews template — frequently asked questions

How do I write a paper in the CNS Drug Reviews format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the CNS Drug Reviews template. When you export, DocuGuru compiles the paper into the official Wiley format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does CNS Drug Reviews use?
CNS Drug Reviews uses Author–year (Chicago) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." CNS Drug Reviews 12 (3): 45–58.
Do I need to know LaTeX to submit to CNS Drug Reviews?
No. DocuGuru generates the USG LaTeX class and compiles the PDF for you in the background, so you get a Wiley-ready CNS Drug Reviews document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the CNS Drug Reviews template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the CNS Drug Reviews format with correct headings, figures, tables, and author–year citations.
Who publishes CNS Drug Reviews?
CNS Drug Reviews is a multidisciplinary journal published by Wiley. DocuGuru's CNS Drug Reviews template matches Wiley's official submission format.
Can I export a submission-ready CNS Drug Reviews PDF?
Yes — DocuGuru produces a PDF built with the official CNS Drug Reviews template (the USG class) that is ready to submit to Wiley, together with the matching LaTeX source files.
How much does the CNS Drug Reviews template cost?
You can start writing in the CNS Drug Reviews template for free. Exporting the final submission-ready CNS Drug Reviews PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the CNS Drug Reviews template